Cargando…
Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome"
BACKGROUND: The "PTEN hamartoma tumor syndrome" (PHTS) includes a group of syndromes caused by germline mutations within the tumor suppressor gene "phosphatase and tensin homolog deleted on chromosome ten" (PTEN), characterized by multiple polyps in the gastrointestinal tract and...
Autores principales: | Galatola, Martina, Paparo, Lorella, Duraturo, Francesca, Turano, Mimmo, Rossi, Giovanni Battista, Izzo, Paola, De Rosa, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353236/ https://www.ncbi.nlm.nih.gov/pubmed/22520842 http://dx.doi.org/10.1186/1471-2350-13-28 |
Ejemplares similares
-
Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome
por: Paparo, Lorella, et al.
Publicado: (2013) -
A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer
por: Turano, Mimmo, et al.
Publicado: (2021) -
PTEN Hamartoma Tumor Syndrome and Immune Dysregulation()()()
por: Eissing, Marc, et al.
Publicado: (2018) -
The Epithelial to Mesenchymal Transition in Colorectal Cancer Progression: The Emerging Role of Succinate Dehydrogenase Alterations and Succinate Accumulation
por: Turano, Mimmo, et al.
Publicado: (2023) -
Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
por: Turano, Mimmo, et al.
Publicado: (2019)